Insider Holders & Insider Ownership - DiaMedica Therapeutics Inc. (DMAC)

List of insiders holdings for DiaMedica Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Von Koch Thomas
TomEnterprise AB
TomEnterprise Private AB
10% Owner
2024-07-01 16:27:160
5,526,435
5,526,435Form 4
STAHLBERG JAN
TRILL AB
10% Owner
2024-07-01 16:24:380
5,221,608
5,221,608Form 4
JACINTO RICHARD II
10% Owner
2023-06-23 17:13:564,558,823
0
4,558,823Form 13G
Xiao Zhenyu
Hermeda Industrial Co. Ltd
Director
10% Owner
2020-12-23 16:31:17936,805
0
936,805Form 13G
Xiao Zhenyu
Director
2020-12-23 16:31:17936,805
0
936,805Form 13G
Wambeke David J.
Chief Business Officer
2024-06-03 17:06:14657,114
0
657,114Form 4
Giuffre Randall Michael
Director
2024-06-03 16:02:39393,023
46,643
439,666Form 4
Pauls Dietrich John
President and CEO
2024-06-03 16:41:13368,591
0
368,591Form 4
Pilnik Richard D.
Director
2024-06-03 16:29:48314,667
0
314,667Form 4
Lorianne Masuoka K.
Chief Medical Officer
2024-01-23 16:23:11285,000
0
285,000Form 4
Kellen Scott
CFO and Secretary
2024-06-03 16:59:09162,290
0
162,290Form 4
Parsons James T.
Director
2024-06-03 16:21:1688,409
0
88,409Form 4
Burroughs Amy L.
Director
2023-01-03 16:36:2773,288
0
73,288Form 4
Verdoorn Todd A.
Chief Scientific Officer
2019-06-26 16:54:0773,025
0
73,025Form 4
Semba Charles Pauling
Director
2024-06-03 16:35:2167,790
0
67,790Form 4
Gruis Kirsten L
Chief Medical Officer
2023-06-02 16:55:4367,000
0
67,000Form 4
Daves Julie VanOrsdel
SVP Clinical Development Oper.
2023-06-02 17:16:3354,000
0
54,000Form 4
ALCORN HARRY W JR
SVP, Clinical Operations
2021-09-15 16:37:4243,582
399
43,981Form 4
Kuntz Richard
Director
2024-06-03 16:09:4042,757
0
42,757Form 4
Lewis Tanya
Director
2024-06-03 16:14:5628,472
0
28,472Form 4
Gilman Sydney A.
VP, Regulatory Affairs
2021-07-29 21:18:2725,000
0
25,000Form 4
Cundari Dominic R
Chief Commercial Officer
2024-06-03 16:58:4917,800
0
17,800Form 4